Shandong Sinobioway Biomedicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 29, 2022 at 08:56 am EDT
Shandong Sinobioway Biomedicine Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 87.39 million compared to CNY 82.56 million a year ago. Revenue was CNY 87.39 million compared to CNY 82.56 million a year ago. Net income was CNY 1.83 million compared to CNY 24.39 million a year ago. Basic earnings per share from continuing operations was CNY 0.0028 compared to CNY 0.037 a year ago. Diluted earnings per share from continuing operations was CNY 0.0028 compared to CNY 0.037 a year ago.